Fegrast is human granulocyte colony-stimulating factor (G-CSF), produced by recombinant DNA technology. Filgrastim is available in prefilled syringe. Filgrastim is in a class of medications called colony-stimulating factors. It works by helping the body make more neutrophils
Filgrastim is used to decrease the chance of infection in people who have certain types of cancer and are receiving chemotherapy medications that may decrease the number of neutrophils
(a type of blood cell needed to fight infection), in people who are undergoing bone marrow transplants, and in people who have severe chronic neutropenia (condition in which there are a low number of neutrophils in the blood).
|
It is indicated in the treatment of:
- Chemotherapy induced neutropenia in Cancer Patients Receiving Myelosuppressive chemotherapy & patients With Acute Myeloid Leukemia Receiving Induction or Consolidation Chemotherapy
- Cancer Patients Receiving Bone Marrow Transplant
- Patients Undergoing Peripheral Blood Progenitor Cell Collection and Therapy
- Patients With Severe Chronic Neutropenia
|
|
